Skip to main content
| News

Roche opens tallest building in Switzerland

05.09.2022

Roche has inaugurated a new office building with 3,200 positions in Basel. Standing 205 meters high, Building 2 is the tallest building in Switzerland and is a symbol of the pharmaceutical company’s commitment to the location of Basel. Lonza also has expansion plans in Basel.

The two Roche towers are the two tallest buildings in Switzerland (img: Roche)

Roche has opened a new office building with 3,200 jobs at its headquarters in Basel. Reaching 205 meters, Building 2 is currently the tallest building in Switzerland. It has 50 floors.

With this new building, the pharmaceutical company is once again showing its commitment to its headquarters in Basel. CEO Severin Schwan commented in the press release: “Building 2 is a further visible symbol of Roche’s commitment to Basel as a location, which is where Roche was established more than 125 years ago. It is a new milestone in our area development, which is creating a highly attractive, modern site for our headquarters.”

Roche has invested 550 million Swiss francs in Building 2. Employees that were previously scattered across various buildings in Basel will come together in the new location. The building provides the opportunity for modern forms of collaboration, from teamwork to focused forms of work and a combination of remote and office work.

According to the press release, the building is “one of the world’s most sustainable high-rise office towers”. It is heated using waste heat from the local area and cooled with groundwater. Additionally, it has an energy-efficient façade, 50 percent of which is glass, and has an underground bicycle store with 400 available spaces. Another building in the area is scheduled to be opened in fall 2024: Roche is currently building a new research and development center costing 1.2 billion Swiss francs.

Lonza also has expansion plans

The chemical and pharmaceutical company Lonza also has big plans in Basel. Two more skyscrapers are to be built next to the existing Lonza high-rise. In addition to commercial and service space required by Lonza, apartments “for different needs” are also planned, according to a statement from the Canton of Basel-Stadt.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Novartis investing 100 million Swiss francs in new biologics center

The pharmaceutical company Novartis is investing a sum of 100 million Swiss francs in a new competence center for biologics...

Read More
Basel Area Business & Innovation, ICT, Innovation, Invest

Official opening of the competence center uptownBasel

uptownBasel celebrated its official opening. Technology companies such as Bouygues and Vinci Energies are already occupying the first building of...

Read More
Basel Area Business & Innovation, Innovation, Life Sciences / biotech, Medtech, Switzerland Innovation Park

Eight startups from Basel Area feature in TOP 100 Swiss Startups

Among the most promising startups in Switzerland eight companies from Basel Area's startup ecosystem have been named. They are some...

Read More
Basel Area Business & Innovation, Invest, Life Sciences / biotech

Roche opens tallest building in Switzerland

Roche has inaugurated a new office building with 3,200 positions in Basel. Standing 205 meters high, Building 2 is the...

Read More
Basel Area Business & Innovation, Innovation, Medtech, Switzerland Innovation Park

DayOne Tech supports three medtech startups

DayOne, the healthcare innovation initiative from Basel Area Business & Innovation, has started its medtech accelerator in the canton of...

Read More
Basel Area achieves milestone with settling of LifeMine
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Basel Area achieves milestone with settling of LifeMine

Life sciences company LifeMine Therapeutics from the USA has established its European headquarters in the Basel Area. With this, Basel...

Read More
1 2 3 57

Do you have a question? We'd like to hear from you.